05/15/2024
11:15 PM | Lexicon Pharmaceuticals (Filer)
| Form EFFECT | |
05/14/2024
4:17 PM | Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Wittouck Amaury (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:00 PM | Amouyal Philippe (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:01 PM | BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:02 PM | DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:03 PM | LEFKOWITZ ROBERT J MD (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
4:14 PM | Lexicon Pharmaceuticals (Filer)
| Form S-3/A | |
|
04/29/2024
3:16 PM | Amouyal Philippe (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
3:17 PM | BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
3:17 PM | DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
3:18 PM | LEFKOWITZ ROBERT J MD (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
3:20 PM | Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
3:21 PM | Lexicon Pharmaceuticals (Issuer)
Swain Judith L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/29/2024
8:00 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
3:05 PM | Lexicon Pharmaceuticals (Filer)
| Form ARS | |
03/26/2024
6:05 AM | Lexicon Pharmaceuticals (Filer)
| Form DEF 14A | |
03/26/2024
6:06 AM | Lexicon Pharmaceuticals (Filer)
| Form DEFA14A | |
03/25/2024
3:17 PM | Lexicon Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/13/2024
8:20 PM | Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/13/2024
8:22 PM | Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Wittouck Amaury (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
3:31 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
6:26 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:31 PM | Lexicon Pharmaceuticals (Issuer)
McDermott Wendy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:32 PM | Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:33 PM | Alexander Kristen (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:37 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Lexicon Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/29/2023
4:27 PM | Lexicon Pharmaceuticals (Filer)
| Form 424B5 | |
12/29/2023
4:29 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
3:55 PM | COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:31 PM | COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
3:16 PM | Lexicon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
6:22 AM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
3:01 PM | DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
3:06 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2023
3:06 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
4:05 PM | Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2023
6:07 AM | Lexicon Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/04/2023
6:09 AM | Lexicon Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/31/2023
3:02 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
7:13 AM | Lexicon Pharmaceuticals (Issuer)
Sullivan Diane E. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/31/2023
7:14 AM | Lexicon Pharmaceuticals (Issuer)
Sullivan Diane E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
07/24/2023
3:01 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2023
3:34 PM | Lexicon Pharmaceuticals (Subject)
Seth Kiernan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/29/2023
3:13 PM | COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2023
3:20 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
3:22 PM | Lexicon Pharmaceuticals (Issuer)
McDermott Wendy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:04 PM | COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:30 PM | Lexicon Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/20/2023
3:10 PM | Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:46 PM | Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Wittouck Amaury (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:31 PM | Lexicon Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
